Data / Form D filings / AVENUE THERAPEUTICS, INC.
AVENUE THERAPEUTICS, INC.: Form D filings
AVENUE THERAPEUTICS, INC., a pharmaceuticals company in Bay Harbor Islands, FL, filed 2 Form D notices with the SEC between 2017 and 2023. The latest, on February 14, 2023, reports $242,537 sold of a $242,537 offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1111 KANE CONCOURSE, SUITE 301, Bay Harbor Islands, FL, 33154
- Phone
- (781) 652-4500
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1644963
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 14, 2023 | New notice | $242,537 | $242,537 | 1 | Jan 27, 2023 | sec.gov | |
| Jan 12, 2017 | New notice | $5,000,000 | $200,000 | $4,800,000 | 3 | Dec 30, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Scott A. Reines, M.D., Ph.D. | Executive Officer | |
| Michael A. Ryan, M.S. | Executive Officer | |
| Faith A. Charles | Director | |
| Curtis A. Oltmans | Director | |
| Lindsay A. Rosenwald, M.D. | Director | |
| David A. Jin | Executive Officer | |
| Alexandra A. MacLean, M.D. | Executive Officer | |
| Neil A. Herskowitz | Director | |
| Jay A. Kranzler, M.D., Ph.D. | Director |
Other pharmaceuticals companies in Florida that filed recently
- DalCor Pharmaceuticals US, LLC $7 million · Aug 28, 2026
Every Form D from the week of Feb 13, 2023 · All recent filings in Florida · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what AVENUE THERAPEUTICS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.